Stock Price
42.42
Daily Change
-1.35%
Yearly
-59.73%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
argenx SE 247.00 -3.90 -1.55% 3.09%
AstraZeneca 8,276.00 -91.00 -1.09% 6.10%
Biogen 235.74 -0.37 -0.16% -3.05%
Genmab 2,535.00 -15.00 -0.59% 7.78%
Gilead Sciences 68.93 -1.72 -2.43% 12.78%
GRIFOLS 15.83 -0.90 -5.38% -34.53%
GlaxoSmithKline 1,525.00 0 0% 10.43%
Hikma Pharmaceutical 2,215.00 -15.00 -0.67% -10.72%
Incyte Corp 67.72 -2.65 -3.77% -20.72%
H Lundbeck A/S 164.85 -0.05 -0.03% -12.31%
Merck 218.90 -0.70 -0.32% 62.51%
Neurocrine Biosciences 83.25 -1.49 -1.76% -12.21%
Novartis 73.44 -0.80 -1.08% -9.75%
Roche Holding 359.65 2.15 0.60% 20.04%
Sanofi 83.86 -1.75 -2.04% -0.29%
UCB 96.14 -0.90 -0.93% 9.35%
Vertex Pharmaceuticals 186.94 -3.17 -1.67% -18.83%

Indexes Price Day Year
NL25 776 -9.62 -1.22% 26.98%
BE20 4113 -26.28 -0.63% 10.64%
EU100 1299 -13.24 -1.01% 18.03%

Galapagos
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In addition, the Company’s mission is to develop a number of medicines based on the discovery of novel targets. Galapagos NV also discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. Galapagos aims to develop small molecules that inhibit these targets, restore the balance and thereby positively influence the course of the disease.